Session information

[JSMN]

Annual Scientific Meeting of the Japanese Society of Nuclear Medicine Program » JSNM Symposium

JSNM Symposium 5
What we need to know before starting clinical Amyloid PET imaging

Sat. Nov 2, 2019 3:00 PM - 5:00 PM Room2 (Matsuyama Multi-Purpose Community Center 3F Conference Room)

Chair：Kazunari Ishii (Kindai University Faculty of Medicine), Toshimitsu Momose (International University of Health and Welfare School of Medicine)

+Add all to schedule

[MSY5-1] 1．Keynote Lecture：What we need to know before starting clinical Amyloid PET imaging

Alexander Drzezga (Department of Nuclear Medicine, University of Cologne, Germany)

[MSY5-2] 2．Amyloid PET using [C-11]PiB

Takashi Kato (Department of Radiology, National Center for Geriatrics and Gerontology)

[MSY5-3] 3．Amyloid PET with F-18 labeled Florbetapir, Flutemetamol, and Florbetaben

Kenji Ishii (Neuroimaging Research, Tokyo Metropolitan Institute of Gerontology)

[MSY5-4] 4．Could next generation amyloid ligands become de facto standards?

Hitoshi Shimada (Department of Functional Brain Imaging Research, National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology)

[MSY5-5] 5．Plasma biomarker for cerebral amyloid deposition using mass spectrometry

Naoki Kaneko (Koichi Tanaka Mass Spectrometry Research Laboratory, Shimadzu Corporation, Kyoto, Japan)

▲